MedTrace Logo

Quality of Life Evaluation After Cataract Surgery Using 4 Types of Intraocular Lens Implant Combinations

NCT05376917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-05-28

No results posted yet for this study

Summary

This is multicenter, prospective, comparative and randomized study focusing on the evolution of the quality of Life and Uncorrected Binocular Visual Acuity (UBVA) evaluation at 3 months after cataract surgery in patients who underwent 4 different types of intraocular lens Implant (IOL) combinations.

Conditions

  • Cataract
  • Intraocular Lens Implant

Interventions

DEVICE

Zeiss CT Asphina / Zeiss CT Asphina

Monovision with refractive target of -1.50D on the dominated eye

DEVICE

Zeiss AT Lara/ Zeiss AT Lisa Tri

Zeiss AT Lara (dominant eye) / Zeiss AT Lisa Tri (non-dominant eye)

DEVICE

Zeiss CT Asphina/ Zeiss AT Lara

Zeiss CT Asphina/ Zeiss AT Lara (non-dominant eye)

DEVICE

Zeiss AT Lara / Zeiss AT Lara

Micromonovision with refractive target of -0.75D on the non-dominant eye

Sponsors & Collaborators

  • Centre Hospitalier Régional Metz-Thionville

    lead OTHER

Principal Investigators

  • Jean-Marc PERONE, MD · Mercy Hospital CHR Metz Thionville

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-30
Primary Completion
2025-05-21
Completion
2025-05-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05376917 on ClinicalTrials.gov